Positron Emission Tomography/Magnetic Resonance Imaging Evaluation of Lung Cancer Current Status and Future Prospects

2014 
Various designs of positron emission tomography/mag- netic resonance imaging (PET/MRI) systems have been recently introduced to clinical practice, which have overcome preexisting technical challenges concerning the fusion of PET and MRI sys- tems. Although further improvements are still necessary especially for bony lesions, quantification using current MRI-based attenu- ation correction techniques has been shown to be comparable to that of PET/computed tomography (CT) systems. On the basis of the results of previous whole-body MRI studies, PET/MRI is expected to show even better performance than PET/CT in M-staging especially for brain and liver metastases. Another advantage of PET/MRI over PET/CT, in addition to good soft tissue contrast, is the potential reduction in radiation dose. The next important hurdle to overcome for its clinical application is the development of time-efficient protocols for lung cancer evaluation and interpretation of discordant results from both modalities. Multiparametric imaging through PET/MRI will help radiologists better understand tumor biology and better evaluate treatment response.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    79
    References
    35
    Citations
    NaN
    KQI
    []